Study of IK-595 in RAS- or RAF-altered Advanced Tumors
Conditions: Solid Tumor, Adult; Colorectal Cancer; Pancreatic Cancer; Malignant Melanoma; Ras (Kras or Nras) Gene Mutation; BRAF Gene Mutation; CRAF Gene Mutation; Non-Small Cell Lung Carcinoma; Thyroid Carcinoma; Gliomas, Malignant Interventions: Drug: IK-595 Sponsors: Ikena Oncology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Genetics | Glioma | Melanoma | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Research | Skin Cancer | Study | Thyroid | Thyroid Cancer